Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 26, 2026ChemMedChem

Aminopeptidase Inhibition in Drug‐Resistant Plasmodium falciparum : Structural, Functional, and Pharmacological Rationale for Targeting PfA‐M1 and PfA‐M17

View Full Paper
Ask AI
Bookmark
Share

Authors

SLSharoen Yu Ming Lim

Discussion

Loading...

Member takes

Overview

Review evaluates aminopeptidase inhibition for antimalarial efficacy in drug-resistant malaria, suggesting new treatment strategies.

Key Points

  • To explore the role of PfA-M1 and PfA-M17 as viable targets in combatting drug-resistant strains of Plasmodium falciparum.
  • Review of structural and functional characteristics of PfA-M1 and PfA-M17.
  • Analysis of current inhibitors including MMV1557817 and compound 26.
  • Discussion on the interaction of these inhibitors with existing antimalarial classes.
  • PfA-M1 and PfA-M17 are validated as essential targets for antimalarial drug strategies.
  • Inhibitors showed substantial fitness costs on resistant parasites, impacting their evolution.
  • Dual inhibition approaches may enhance therapeutic efficacy against drug-resistant malaria.

Cite This Study

Sharoen Yu Ming Lim (2026) studied this question.

synapsesocial.com/papers/6a65a501d3aea3239cd77533https://doi.org/10.1002/cmdc.70401
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Structure-guided targeting of Plasmodium falciparum aminopeptidase P: exploiting S4′ dimer-interface interactions for selective antimalarial drug design2026
  2. 2Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as an antimalarial strategy2024
  3. 3Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as an antimalarial strategy2024 · 8 citations
  4. 4Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as an antimalarial strategy2024
  5. 5Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as an antimalarial strategy2024